| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/15/2004 | US20040136953 diagnosing aggressive form of respiratory condition by a different T helper cell response when samples are incubated with antigen characteristic of condition; treatment with interferon gamma |
| 07/15/2004 | US20040136875 Chips in fluid confinement regions |
| 07/15/2004 | US20040135997 Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (SERS) substrate |
| 07/15/2004 | US20040135996 Biosensor with an arbitrary substrate that can be characterised in photothermal deflection |
| 07/15/2004 | US20040134798 Sensing apparatus and method |
| 07/15/2004 | US20040134797 Lactate biosensing strip and method for manufacture thereof |
| 07/15/2004 | US20040134387 obtained from plant by-products or waste suspended through wet-grinding and suspended by means of a microballs mill; includes silica fume, fly ashes, heavy ashes, slags or stone sludge, in form of pellets, sludge or blocks |
| 07/15/2004 | DE19581489B4 Mit Energieübertragungs-gekuppelten Farbstoffen markierte Sonden With energy transfer coupled dyes labeled probes |
| 07/15/2004 | DE10261468A1 Test kit for detecting Brucella species, potential biological warfare agents, in the environment, comprises primers for specific amplification, optionally also hybridization probe |
| 07/15/2004 | DE10260927A1 Verfahren zur Bestimmung des enzymatischen Status humaner Haut in vitro Method for determining the enzymatic status of human skin in vitro |
| 07/15/2004 | DE10258885A1 Verfahren zur Generierung eines gentechnisch veränderten Organismus Method for generating a genetically modified organism |
| 07/15/2004 | DE10230141B4 Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) Method and kit for the enrichment and detection of altered prion protein (PrPSc) |
| 07/15/2004 | CA2777534A1 Methods, compositions and kits for biomarker extraction |
| 07/15/2004 | CA2774928A1 Binding agents which inhibit myostatin |
| 07/15/2004 | CA2756797A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | CA2692217A1 Markers for differential diagnosis and methods of use thereof |
| 07/15/2004 | CA2512380A1 Cholesterol enzyme electrode |
| 07/15/2004 | CA2511656A1 Coenzyme-binding glucose dehydrogenase |
| 07/15/2004 | CA2511620A1 Nucleotide derivatives and dna microarray |
| 07/15/2004 | CA2511501A1 Markers for differential diagnosis and methods of use thereof |
| 07/15/2004 | CA2511436A1 Centrosome-associated protein and applications thereof |
| 07/15/2004 | CA2511372A1 Methods, compositions and kits for biomarker extraction |
| 07/15/2004 | CA2511012A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | CA2510895A1 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof |
| 07/15/2004 | CA2510891A1 Rapid direct sequence analysis of multi-exon genes |
| 07/15/2004 | CA2510774A1 Amplified cancer target genes useful in diagnosis and therapeutic screening |
| 07/15/2004 | CA2510587A1 Nucleic acid amplification |
| 07/15/2004 | CA2510561A1 Malate dehydrogenase as a target for herbicides |
| 07/15/2004 | CA2510362A1 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | CA2510314A1 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | CA2510311A1 Novel therapeutic targets in cancer |
| 07/15/2004 | CA2509999A1 Btl-ii nucleic acids, proteins, and antibodies |
| 07/15/2004 | CA2508944A1 Novel compositions and methods in cancer |
| 07/15/2004 | CA2508610A1 Assay for rnase h activity |
| 07/15/2004 | CA2508228A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | CA2508072A1 Protecting luciferase activity from luciferase enzyme interfering compounds using detergents for the accurate measurement of luciferase activity |
| 07/15/2004 | CA2504198A1 Combined exponential and linear amplification |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1437673A1 Method for the identification of microorganisms by mass spectrometry |
| 07/14/2004 | EP1437596A1 N- or C-terminal peptide selection method for proteomics |
| 07/14/2004 | EP1437595A1 Orphan GPCR gene 115 for obesity indication |
| 07/14/2004 | EP1437594A1 Luminescent polymer and use thereof in bioassay |
| 07/14/2004 | EP1437418A1 Selecting animals for desired genotypic or potential phenotypic properties based on a single nucleotide polymorphism (SNP) in intron 3 of the IGF2 gene |
| 07/14/2004 | EP1437417A1 Beta-catenin oligonucleotide michrochip and method for detecting beta-catenin mutations employing same |
| 07/14/2004 | EP1437416A1 Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters |
| 07/14/2004 | EP1437368A1 Composition for polymerising immobilisation of biological molecules and method for producing said composition |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1437043A1 Model animal with overexpression of regucalcin |
| 07/14/2004 | EP1436761A2 Nanomachine compositions and methods of use |
| 07/14/2004 | EP1436756A2 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 07/14/2004 | EP1436630A2 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 07/14/2004 | EP1436629A1 Universal microscope slide cassette |
| 07/14/2004 | EP1436628A2 A method for predicting an increased likelihood of antiphospholipid syndrome in a patient |
| 07/14/2004 | EP1436625A2 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436623A1 Modulation of tor |
| 07/14/2004 | EP1436621A1 Multi-analyte assay device with multi-spot detection zone |
| 07/14/2004 | EP1436620A2 Methods and apparatus for conducting multiple measurements on a sample |
| 07/14/2004 | EP1436619A2 Methods for producing ex vivo models for inflammatory disease and uses thereof |
| 07/14/2004 | EP1436618A2 Muscle sample prepared for prion assay |
| 07/14/2004 | EP1436614A1 Methods of detection of conformational change in a nucleic acid duplex by treatment with oxidising or reactive agent as a result of exposure to environmental or chemical conditions |
| 07/14/2004 | EP1436613A1 Method for evaluating a patient's biological condition |
| 07/14/2004 | EP1436611A2 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries |
| 07/14/2004 | EP1436609A2 Microfluidic extraction method |
| 07/14/2004 | EP1436603A2 Electro thermometric method and apparatus |
| 07/14/2004 | EP1436598A1 Assay buffer, compositions containing the same, and methods of using the same |
| 07/14/2004 | EP1436586A2 Automated system and method for processing multiple liquid-based specimens |
| 07/14/2004 | EP1436585A1 Apparatus and method for mixing specimens in vials |
| 07/14/2004 | EP1436584A1 Vial system and method for processing liquid-based specimens |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436428A2 Process for the detection of chromosomal aberrations in interphase nuclei |
| 07/14/2004 | EP1436427A2 Methods and compositions to evaluate antibody treatment response |
| 07/14/2004 | EP1436426A2 Methods for detecting genetic haplotypes by interaction with probes |
| 07/14/2004 | EP1436425A2 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 07/14/2004 | EP1436424A2 Differential tagging of polymers for high resolution linear analysis |
| 07/14/2004 | EP1436423A2 Genetic analysis for stratification of cancer risk |
| 07/14/2004 | EP1436422A2 Method of determining susceptibility to inflammatory bowel disease |
| 07/14/2004 | EP1436421A2 Methods for detecting ovarian cancer |
| 07/14/2004 | EP1436420A2 Test strip assay system and method for the detection of specific nucleic acid sequences |
| 07/14/2004 | EP1436419A1 Methods for detection of target molecules and molecular interactions |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436417A1 Molecular typing of group b streptococci |
| 07/14/2004 | EP1436416A2 Method for detecting and identifying the presence of biological materials derived from fish, and oligonucleotides therefor |
| 07/14/2004 | EP1436415A2 Nucleic acid triplex and quadruplex formation |
| 07/14/2004 | EP1436414A1 DETECTION OF i RPOB /i SEQUENCES OF i MYCOBACTERIUM TUBERCULOSIS /i |
| 07/14/2004 | EP1436413A2 Response of dendritic cells to a diverse set of pathogens |
| 07/14/2004 | EP1436412A2 Method for modelling hydrocarbon degradation in an oil deposit |
| 07/14/2004 | EP1436411A2 Chromogenic enzyme substrates and method for detecting beta-d-ribofuranosidase activity |
| 07/14/2004 | EP1436408A1 A method for identifying effector molecules for gene network integration |
| 07/14/2004 | EP1436407A1 Amperometric sensor |
| 07/14/2004 | EP1436406A2 Method of modulating or examining ku70 levels in cells |
| 07/14/2004 | EP1436404A2 Engineered templates and their use in single primer amplification |
| 07/14/2004 | EP1436401A1 Stem-loop vector system |
| 07/14/2004 | EP1436398A2 Glucosyltransferases which glucosylate abscisic acid |
| 07/14/2004 | EP1436394A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/14/2004 | EP1436393A2 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/14/2004 | EP1436391A2 Low-temperature cycle extension of dna with high priming specificity |
| 07/14/2004 | EP1436387A2 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n-acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 07/14/2004 | EP1436385A2 Dna polymerases and mutants thereof |
| 07/14/2004 | EP1436384A2 Mutated abl kinase domains |